
Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Venture capital firm investing worldwide in bioelectronic medicine startups and their enabling technologies

Action Potential Venture Capital is a medical technology venture capital firm set up by GSK in 2013. It invests around the world in young companies advancing bioelectronic medicines, a field that treats chronic disease by regulating neural or cellular activity. The firm takes an active part on the boards of the startups it backs.
Innovators and entrepreneurs in bioelectronic medicine. Portfolio names mentioned on its site include Saluda Medical and SetPoint Medical.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Action Potential Venture Capital.
Similar listings buyers compare against this one.

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Venture capital firm partnering with founders from first idea through to public listing

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications

New York investment company developing, building and operating community and commercial solar projects

A liquidity and market-making services provider for Web3 token projects and exchanges

A Swiss venture capital firm backing early-stage biotech companies in continental Europe
Everything here links back to the same verified catalogue. Pick your next stop.